** Sera Prognostics Inc's SERA.O down 7.6% in extended trading to $4.11 as it looks to raise equity
** Salt Lake City-based women's health co commences offering comprising stock and pre-funded warrants without disclosing deal size
** Co says plans to use net offering proceeds to expand commercial infrastructure in the U.S., accelerate preparations for expansion in the European Union, fund additional studies to increase adoption of its blood test to predict preterm birth risks, PreTRM, including a potential submission to U.S. FDA for broad approval
** Jefferies, TD Cowen and William Blair jt bookrunners for offering, joined by RBC
** Co has ~33.77 mln shares outstanding giving it a current market cap of ~$150 mln, per LSEG
** SERA shares on Mon closed down 2% at $4.45, extending YTD decline to 45%
(Lance Tupper is a Reuters market analyst. The views expressed are his own)
((lance.tupper@tr.com 1-646-279-6380))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。